Aligos Therapeutics (ALGS)

• Market cap: $49.1M
• 1 day: -0.42%
• 5 days: -14.61%
• 1 month: -28.15%
• 3 months: -13.04%
• 6 months: 62.16%
• Year to date: -82.25%
• 1 year: -28.73%
• 5 years: -98.43%
• 10 years: -98.1%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70